|
Hear a 5-minute summary of a post hoc analysis of the LEADER trial investigating whether frequency of non-severe hypoglycemic episodes is associated with severe hypoglycemia, major adverse cardiovascular events, cardiovascular death, and all-cause mortality. Listen for a quick overview of the key findings.
Publication: Heller SR, Geybels MS, Iqbal A, et al. A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study. Diabetologia (2021) https://doi.org/10.1007/s00125-021-05556-7
Additional references: Heller S, Lingway I, Marso SP, et al. Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE. Diabetes, Obes Metab. 2020;22(12):2241-2247.
Zinman B, Marso SP, Christiansen E, et al. Hypoglycaemia, cardiovascular outcomes, and death: the LEADER experience. Diabetes Care. 2018;41(8):1783-1791.
For more free education, visit the DKIP website, follow us on Twitter (@dkipractice) or connect on LinkedIn.
Target Audience
This educational activity is intended for an international audience of non-US and non-UK HCPs.
Funding statement:
This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education. |